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Abstract
Background: Our understanding of the factors influencing the emergence, dissemination and global distribution of
epidemic clones of bacteria is limited. ST59 is a major epidemic clone of community-associated MRSA in East Asia,
responsible for extensive morbidity and mortality, but has a much lower prevalence in other parts of the world. The
geographic origin of ST59 and its international routes of dissemination are unclear and disputed in the literature.
Results: To investigate the origin and spread of the ST59 clone, we obtained whole genome sequences of isolates
from four continents, sampled over more than a decade, and carried out a time-scaled phylogeographic analysis.
We discover that two distinct ST59 clades emerged concurrently, in East Asia and the USA, but underwent clonal
expansion at different times. The East Asia clade was strongly enriched for gene determinants associated with
antibiotic resistance, consistent with regional differences in antibiotic usage. Both clones spread independently to
Australia and Europe, and we found evidence of the persistence of multi-drug resistance following export from East
Asia. Direct transfer of strains between Taiwan and the USA was not observed in either direction, consistent with
geographic niche exclusion.
Conclusions: Our results resolve a longstanding controversy regarding the origin of the ST59 clone, revealing the
major global source and sink populations and routes for the spread of multi-drug resistant clones. Additionally, our
findings indicate that diversification of the accessory genome of epidemic clones partly reflects region-specific
patterns of antibiotic usage, which may influence bacterial fitness after transmission to different geographic
locations.
Background
Since the 1990s, methicillin-resistant Staphylococcus
aureus (MRSA) strains have been identified outside the
hospital setting, often in otherwise healthy individuals
with no obvious recent healthcare-associated risk factors
(reviewed in [1]). These strains, termed ‘community-
associated’ MRSA (CA-MRSA), are suggested to represent
a pool of strains which are distinct from healthcare-
associated MRSA (HA-MRSA) and have been found to
possess novel SCCmec types (IV and V rather than I–III)
[2, 3] and to encode toxins such as Panton-Valentine
leukocidin (PVL) [4, 5].
Whilst many CA-MRSA clones have a global distri-
bution, the considerable variation in the prevalence
and dominance of clones between different geograph-
ical niches remains unexplained. For example, in the
USA, the ST8 USA300 clone is the dominant epi-
demic clone, responsible for very high levels of hu-
man disease and mortality over more than a decade
[6, 7]. In contrast, S. aureus clonal complex 59
(CC59) is a major CA-MRSA clone in East Asia and
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is the dominant clone in Taiwan [8–10], where it is a
major cause of skin and soft tissue infections [11]
and has also been identified as a widespread com-
mensal coloniser (discussed in [12]). CC59 colonisa-
tion or infection has been reported in many countries
globally, including the USA [6, 13], where the
USA1000 ST59 strain is found, but the prevalence is
much lower compared with East Asia.
Previous studies have devised groupings for CC59
strains according to variation in SCCmec elements and
carriage of PVL, with one such group being the virulent
‘Taiwan clone’ which included ST59, ST338 and ST952
isolates [14]. In addition to being PVL-positive, the
Taiwan clone has been shown to possess a novel type V
SCCmec element, known as V[5C2&5] or VT [15]. A
recent comparative genomics study using microarray
data has indicated that Taiwanese ST59 strains may be
distinguished between the Taiwan clone and a distinct,
commensal ‘Asia-Pacific’ clone (SCCmec type IV, PVL-
negative) on the basis of carriage of specific mobile
genetic elements [12]. The prevalence of multi-drug re-
sistance amongst both skin and soft tissue infection and
commensal ST59 isolates in Taiwan has been reported
to be unusually high compared with other CA-MRSA
strains [16].
Phylogenetic studies across the whole diversity of
S. aureus have speculated upon the ancestral origins
of CC59, suggesting that it emerged through a host
jump from livestock into humans at least 500 years
ago [17, 18]. The global spread of CC59 strains has
also been the subject of controversy in the literature,
with suggestions that ST59 originated in the USA
and spread eastwards towards Asia and/or that there
has been spread of ST59 out of Taiwan [19, 20].
Proposals regarding the geographical origins of ST59
strains are based upon case reports and multi-locus
sequence typing of CA-MRSA isolates and are thus
highly influenced by the order in which isolates are
reported. For example, the USA was the only coun-
try from which ST59 was found in a 2003 study of
CA-MRSA strains; along with the apparent finding
of continent-specific clones, this led researchers to
conclude that CA-MRSA ST59 originated in the USA
[21]. Subsequent reports of CA-MRSA ST59 isolated in
Taiwan between 1997 and 2002 [22], followed by its
discovery in Singapore, the Netherlands and France,
indicated that CA-MRSA has spread at the inter-
continental level and led some researchers to con-
clude that exchange of USA1000 ST59 had occurred
from the USA towards Asia [23], although this re-
mains a point of contention [19].
To date, little is known about the relative timings
of the expansions of the USA1000 and Taiwan ST59
clones. Using whole-genome phylogeographic analyses,
we formally test hypotheses about the spread of ST59
between different countries or continents and investi-
gate the evolutionary relationships between them. We
describe the spatiotemporal spread of CC59 using a
dataset of 120 global CC59 genomes, investigate the
distribution of mobile genetic elements in CC59
strains from around the world and consider the po-
tential influence of inter-clone competition on the
global distribution of CA-MRSA strains.
Results
Distinct clades of CC59 originated in USA and East Asia
We carried out whole-genome sequencing of 120 human
CC59 isolates from Australia, the Netherlands, Taiwan,
the UK and the USA, sampled between 1998 and 2011,
including reference isolates (Additional file 1: Figure S1,
Figure S2 and Table S1). Two major clades, each with a
posterior probability of 1, were identified in a time-
scaled BEAST phylogeny constructed from the core gen-
ome (Fig. 1a). One clade consisted of sequences from
the USA, Australia and the UK, with the other compris-
ing sequences from Taiwan, Australia, the UK and the
Netherlands. Notably, while isolates from Europe and
Australia were found in both clades, we observed a clear
phylogenetic separation between CC59 strains from
Taiwan and the USA. The same split into two major
clades was observed in a maximum likelihood phylogen-
etic analysis of core genome sequences (Additional file 1:
Figure S3).
There was considerable difficulty in placing a group of
five sequences (three from Australia and two from the
UK) in the BEAST analysis, as indicated by low posterior
support for their position in the tree (Additional file 1:
Figure S4). The presence of these five sequences in the
analysis did not affect our overall phylogenetic conclu-
sions (emergence dates and composition of the two
major clades remained the same when the analysis was
run without them).
Phylogeographic mapping of the country of sam-
pling onto the BEAST phylogeny samples indicated
the clade containing Taiwanese isolates had its ances-
tral location in Taiwan (posterior probability (PP) = 0.92)
and that the other major clade had its ancestral loca-
tion in the USA (PP = 0.99). We henceforth refer to
these clades as the ‘East Asia clade’ and the ‘USA
clade’, respectively. The East Asia and USA clades emerged
around the same time: 1966 for the USA clade (95 % high-
est posterior density (HPD) interval = [1959, 1973]); 1971
for the East Asia clade (95 % HPD interval = [1965, 1977]).
However, plots of the relative genetic diversity of
CC59 over time are consistent with the hypothesis
that the expansion of the USA clade preceded the ex-
pansion of the East Asia clade by approximately 10 years
(Fig. 1a, b).
Ward et al. Genome Biology  (2016) 17:160 Page 2 of 13
CC59 has spread on an intercontinental scale but with
geographical restriction between Taiwan and the USA
Isolates from Australia and Europe were interspersed
across both the USA and East Asia clades, suggestive of
frequent inter-continental spread of CC59. Within the
East Asia clade we observed a sub-clade (PP = 1; denoted
by black square in Fig. 1a) of seven sequences from the
Netherlands, sampled between 2003 and 2007 and shar-
ing a common ancestor around 2000. Similarly, within
the USA clade, a sub-clade of five sequences sampled in
Australia
USA
UK
Taiwan
Netherlands
Location
PP=1
PP=1
1950 1960 1970 1980 1990 2000 2010
Year
USA PP=0.99
Taiwan (E. Asia)
PP=0.92
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diversity
a
b
1x100
1x101
1x102
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Fig. 1 Maximum clade credibility (MCC) tree showing a the phylogenetic relationships between global CC59 sequences and b the relative
genetic diversity of global CC59 over time. The MCC tree is summarised from 9000 BEAST posterior phylogeny samples. Branches are coloured
according to the inferred ancestral location under a discrete phylogeography analysis. Due to low power at the root of the tree, we were unable
to infer the ancestral location with a posterior probability greater than 0.5 (branches coloured black). Purple dots denote the ancestral nodes of
two major clades, one which was inferred to have originated in the USA and the other in East Asia. A black triangle denotes a clade of sequences
from the UK found within the USA-associated clade and a black square denotes a clade of sequences from the Netherlands found within the East
Asia clade. Median and 95 % highest posterior density (HPD) intervals for the relative genetic diversity of CC59 over time are plotted against time,
with the lower limit of the timescale corresponding to the lower 95 % HPD value of the root height of the tree. The phylogeny and the plot of
the relative genetic diversity are shown on the same timescale. PP posterior probability
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the UK between 2000 and 2009 which shared a common
ancestor in the mid-1990s was observed (PP = 1; denoted
by black triangle in Fig. 1a), suggesting that ST59 is able
to be maintained and cause outbreaks following dissem-
ination from East Asia or the USA.
We used discrete trait mapping ‘Markov jumps’
methods in BEAST to summarise the number of transi-
tions into and out of individual countries and identify
major exporters and importers of CC59 (Fig. 2). We ob-
served significantly more transitions into the UK, the
Netherlands and Australia than into the USA and
Taiwan. In contrast, the highest number of exports was
out of Taiwan. On the basis of these analyses, Australia,
the UK and the Netherlands were identified as sink
populations for ST59, whilst Taiwan and the USA
were identified as source populations. The median
number of transitions from one country to another
was calculated across the BEAST phylogeny samples
and plotted as a heat map (Fig. 3). The highest num-
bers of transitions, and the only directed links for
which the lower 95 % HPD limit was greater than 0,
were from Taiwan into the UK (median number of
transitions = 9, 95 % HPD interval = [6, 13]), from
Taiwan into the Netherlands (median number of tran-
sitions = 6, 95 % HPD interval = [4, 9]), and from the
USA into the UK (median number of transitions = 6,
95 % HPD interval = [2, 11]).
Bayes factor support for links between countries in a
parsimonious description of the dissemination of CC59
was assessed through a Bayesian stochastic search vari-
able selection (BSSVS) analysis. Strongly supported links
(Bayes factor greater than 20) were found between the
Taiwan and the Netherlands, between Taiwan and the
UK and between Australia and the UK. The most
strongly supported link involving the USA was between
the USA and Australia; this was the fourth most strongly
supported link in all independent BEAST runs, with a
Bayes factor of approximately 3.
We assessed the robustness of results from the phylo-
geographic analysis to sampling effects by re-running
the BEAST analyses on multiple down-sampled CC59
sequence datasets. In half of the runs we sampled from
all countries across the entire period for which data were
available (1998–2011), whilst in the other half we only
sampled sequences from 2002 or later, as there were few
sequences from countries other than Taiwan prior to
2002. The results from the subsampling analysis were
highly consistent with our findings from the full dataset
(Additional file 1: Figures S5–S9). Overall, these data im-
plicate East Asia and the USA as the main global reser-
voirs for CC59, and we can identify major routes of
intercontinental dissemination from those countries to
Australia and Europe. Our data do not demonstrate
transmission between Taiwan and the USA, in either dir-
ection, contrary to published assertions regarding the
spread of CC59 between those countries [23]. Analysis
of five independent phylogeography runs was not able to
reliably estimate the geographical location at the root of
the tree, with different locations being identified as the
most probable ancestral location in different runs and al-
ways with a low PP (lower than 0.5).
Fig. 2 Inferred number of CC59 imports and exports. The median
number of transitions out of and into each country, as inferred using
a Markov jumps analysis, was calculated across the BEAST phylogeny
samples. The 95 % HPD intervals are shown as lines, with medians
indicated by dots. Australia, the Netherlands and the UK were
inferred to be sink populations for ST59, with Taiwan/East Asia and
the USA as source populations
Fig. 3 Inferred number of transitions between locations. The median
number of transitions from one location to another under the
Markov jumps analysis was calculated across the BEAST phylogeny
samples. Lighter blocks in the heat map indicate a higher number of
transitions. The highest numbers of transitions were from Taiwan to
Australia and the UK and from the USA to the UK
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CC59 isolates from USA and Taiwan have accessory
genomes with distinct antibiotic resistance gene profiles
In order to test the hypothesis that there were differ-
ences in gene content between the East Asia and USA
clades which reflected their distinct geographic origins,
we performed pangenomic analysis of all 120 CC59
isolates, identifying a total of 1420 accessory genes (i.e.
genes not found in all isolates). We analysed the distri-
bution of the accessory genes across the core genome
phylogeny of the 120 CC59 sequences and used agglom-
erative hierarchical clustering to group the strains ac-
cording to the presence or absence of accessory genes.
We found that the most basal split into two clusters cor-
responded exactly with membership of the East Asia or
USA clades in the core genome phylogeny (Additional
file 1: Figure S10). Under Fisher’s exact test with a mul-
tiple testing correction, 153 genes were identified as sig-
nificantly differing in presence or absence between the
USA and East Asia clades. Only minor variation was ob-
served in the number of core and accessory genes identi-
fied when different sequence similarity cutoffs (70, 80 or
90 %) were used in the pangenome analysis.
For genes identified as associated with presence in ei-
ther the East Asia or USA clade and absence in the
other, we noted whether there was evidence in the litera-
ture of involvement in antibiotic resistance or bacterial
virulence or pathogenicity. We also looked for genes as-
sociated with competition which differed significantly in
their presence between the USA and East Asia clades to
investigate potential differences between the clades
which might account for the observed lack of transfer of
ST59 between the USA and Taiwan. From the Prokka
annotation we identified a bacteriocin biosynthesis op-
eron which was present in 75 % of isolates in the USA
clade and 0.08 % of isolates in the East Asia clade. The
encoded bacteriocin sequence (97 amino acids in length)
was identical at the amino acid level for all CC59 isolates
in our study in which it was found. BLAST searches
found matches to the sequence with a very high level of
coverage and similarity (both greater than 90 %)
amongst S. aureus genomes from GenBank, as well as to
an apparent variant (approximately 90 % coverage and
50 % sequence identity), both of which were found
amongst USA300 strains. The existence of other genes
in the same genomic region, with identical patterns of
presence or absence across the CC59 isolates, suggests
multiple genes have been imported or lost simultan-
eously with the bacteriocin. This is consistent with the
bacteriocin being encoded on a plasmid, as was observed
for publicly available genomes, including some belonging
to USA300 (e.g. CP002146.1).
In addition to the assembly-based pangenome analysis
described above, we mapped the sequencing short reads
to gene sequences in reference databases for S. aureus
antibiotic resistance. This allowed us to assess the pres-
ence and absence of known resistance genes for each
CC59 isolate. Consistent with the pangenome analysis,
the mapping analysis revealed six antibiotic resistance
genes (catA, ermB, mecA, tetK, ant(6)-Ia, aph(3)-III)
which were significantly associated with presence in
the CC59 isolates from Taiwan and absence in CC59
isolates from the USA, whilst no resistance genes
were associated with presence in the USA isolates
and absence in the Taiwan isolates (Fig. 4 and
Table 1). Our data suggest that, in contrast to most
isolates in the USA clade, the Taiwanese isolates have
acquired genes conferring resistance to beta-lactams,
chloramphenicol, tetracyclines and macrolides (or that
the genes were lost from the USA clade but not from
the East Asia clade).
Within the USA and East Asia clades, some variation
could be observed between the antibiotic resistance pro-
files of isolates from different countries (Fig. 4). For ex-
ample, only 31 % of USA isolates had the mecA gene
and these strains were distributed across the USA clade,
whereas a subclade of eight isolates from the UK and
Australia within the USA clade all carried mecA, al-
though such observations could be affected by sampling.
Evidence was observed for the local acquisition of resist-
ance determinants within countries: the only isolates in
our study to possess amino acid variants in the gyrA and
grlA genes associated with ciprofloxacin resistance were
a subclade of five isolates from Australia and the UK
that fell within the USA clade. Analysis of the 95 % HPD
intervals for the dates of the branch immediately preced-
ing this clade yielded an estimate of 1983–1995 for the
emergence of fluoroquinolone resistance in UK strains
of ST59, concordant with phylogenetic estimates for
healthcare-associated S. aureus in the UK [24], although
with a wider HPD interval due to lower power (fewer re-
sistant strains, from across a smaller timespan) in our
dataset. Drug-resistant strains may also spread from one
country to another. For example, whilst the ermB gene
was absent in all isolates within the USA clade, including
those from Europe and the USA, within the East Asia
clade it was present in 93 % of isolates from Taiwan and
78 % of European and Australian strains, consistent with
the spread of the resistant strains out of East Asia. Simi-
larly, catA was absent in all but one isolate in the USA
clade but present in 86 % of isolates from Taiwan and 74
% of isolates from Europe and Australia within the East
Asia clade. There is evidence that resistance determi-
nants may have been maintained and spread in local
communities after export from Taiwan. For example,
in a sub-clade of seven isolates from the Netherlands
(sampled between 2003 and 2007) within the East
Asia clade, ermB was present in all but the most re-
cently sampled isolate.
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Having determined from the sequencing data whether
genes encoding PVL (lukS/F) were present or absent in
our 120 isolates, we found that there was a significant
difference in distribution between the USA and East
Asia clades. Although isolates in the East Asia clade
were generally more likely to carry PVL genes (61 % of
the East Asia clade and 6 % of the USA clade were PVL
gene-positive), a difference in PVL gene carriage was
also observed within the two major subclades of the East
Asia clade (Fig. 4), where 4 % (1/26 isolates) and 93 %
(53/57 isolates), respectively, were PVL gene-positive.
The split within the East Asia clade into one clade asso-
ciated with the presence of PVL genes and the other as-
sociated with their absence corresponded closely with
Table 1 Antibiotic resistance genes associated with presence in
the East Asia ST59 clade and absence in the USA ST59 clade
Gene associated with presence in East Asia
clade and absence in USA clade
Antibiotic(s) to which
resistance conferred
catA Chloramphenicol
ermB Macrolides, lincosamides,
streptogramins B
mecA Beta-lactams
tetK Tetracyclines
ant(6)-Ia Aminoglycosides
aph(3)-III Aminoglycosides
Presence of genes was determined by mapping short read sequence data to a
database of reference genes using the method described in [57]. The distribution
of antibiotic resistance genes across the CC59 isolates is depicted in Fig. 4
Fig. 4 Presence or absence of antibiotic resistance genes amongst global CC59 isolates. SRST2 was used to map the raw sequencing reads for
CC59 isolates against the ARG-ANNOT database of genes known to be associated with antibiotic resistance. The distribution of genes is plotted
against the core genome phylogeny, with presence of a gene indicated by a blue rectangle. Column names are in the form “X_Y”, where X is the
abbreviated name of the gene, and Y is the abbreviated name of the class(es) of antibiotic to which the gene is associated with resistance. The
presence of amino acid variants associated with ciprofloxacin resistance is plotted, with resistant genotypes indicated in blue (e.g. A_BCD, where
A is the gene name, C is the position of the variant amino acid, B is the residue of the susceptible wild type and D is the residue of the resistant
type). Presence of Panton-Valentine leukocidin (PVL) is also indicated by blue rectangles and a subclade of the East Asia clade associated with PVL
carriage is indicated by a yellow dot
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the second most basal split in the hierarchical clustering
analysis of the whole accessory genome, which separated
isolates in the East Asia clade into two clusters (Fig. 4;
Additional file 1: Figure S10).
Discussion
In this study we used whole genome analysis to shed
light on the intercontinental transmission of S. aureus
CC59 and determined the ancestral relationships be-
tween CC59 isolates from five countries around the
world (Australia, the Netherlands, Taiwan, the UK and
the USA), resolving a long-standing mystery in the field.
From the whole-genome sequencing data we described
the distribution of genes encoding antibiotic resistance
and bacterial virulence across the phylogeny to predict
the phenotypic properties of the isolates.
Our core genome analysis supported the existence of
two major clades, one originating in the USA and the
other in East Asia. No evidence was obtained for the hy-
pothesis, discussed previously in the literature [20] and
based on the timing of case reports, that the ‘Taiwan
clone’ of ST59 previously identified in the literature
emerged as a descendent of USA1000. Rather, the East
Asia clade (which includes strains from Taiwan) and the
USA clade of ST59 appear to have emerged independ-
ently at similar times, in the 1960–1970s. A literature
survey of published ST59 isolates (as of 29 May 2015)
indicates that the earliest ST59 isolates reported are
from 1994 in Taiwan and 1995 in the USA and that
ST59 has been found in both countries simultaneously
through to the present decade. Although we could not
determine which clade originated first, the Bayesian sky-
ride plot indicated that the expansion of the USA clade
could have preceded the expansion of the East Asia
clade. The expansion of the East Asia clade could specu-
latively relate to temporal differences in antibiotic use,
for example the introduction of a new drug, and/or ac-
quisition of an antibiotic resistance determinant. Of po-
tential note, the CC59 isolate from Taiwan which joins
at the most basal node of the East Asia clade lacked a
number of resistance genes, including catA, ermB,
ant(6)-Ia and aph(3)-III, which were present in the ma-
jority of isolates from Taiwan.
Our finding of distinct subclades within the East Asia
clade in terms of core genome, in addition to a distinct
accessory genome profile including differences in PVL
carriage, is consistent with reports in the literature based
on laboratory typing and lower-resolution molecular
methods which indicate that ST59 isolates from Taiwan
belong to two clones. In particular, previous studies have
speculated upon the existence of a ‘Taiwan clone’ (PVL-
positive, SCCmec type VT) and an ‘Asian-Pacific clone’
(PVL-negative, SCCmec type IV) of ST59 [8, 12]. It is
likely that our two major subclades within the East Asia
clade, both of which contain isolates from Taiwan, cor-
respond to these two clones.
Phylogenetic discrete-trait mapping methods provide a
quantitative, hypothesis-driven framework for identifying
sink and source populations for infection, in terms of
geographic region, host populations, or species (e.g.
[25–27]). Our results demonstrated the repeated
transfer of CC59 between countries and continents,
emphasising the ability of CA-MRSA strains to cross
borders and highlighting the need for greater world-
wide surveillance as a matter of global health import-
ance. We identified the USA and East Asia as source
populations for CC59, consistent with epidemiological
inferences in the literature [19, 20], and Europe and
Australia as sink populations. Hierarchical clustering
analysis based upon the presence or absence of
accessory genes indicated that isolates which belonged
to the same major clade (USA or East Asia) in the
core genome phylogeny also had more similar accessory
gene content, similar to a previous observation for
pneumococci [28].
The 120 isolates in our study were chosen from global
CC59 samples to maximise spatiotemporal diversity. The
high levels of consistency between results for the full
dataset and the subsampled runs indicated that our
BEAST analyses were not unduly influenced by uneven
sampling (e.g. with regard to date) within the countries
from which isolates were sequenced. We noted some
sensitivity of the Bayesian skyline plots to sampling at
later sampling times, consistent with previous reports
[29]. Bayes factor support for links between countries,
which has been suggested to be influenced by rare
events [30], was also observed to be sensitive to sam-
pling. The USA isolates in our study were predominantly
commensal methicillin-sensitive S. aureus (MSSA)
whereas a large number of the Taiwan isolates were from
invasive MRSA infections (Additional file 1: Table S1); it
is not clear whether this reflects sampling heterogeneity
or genuine biological differences in the ability of ST59
strains in the USA and Taiwan to cause human infec-
tion. Although many of the USA isolates were from the
American Midwest, they were diverse and strains from
Western USA, Southwestern USA and USA1000 refer-
ence strains (NARSA-483 and NARSA-676) from the
Northeast were interspersed amongst them in the core
genome phylogeny. Future phylogenomics studies could
investigate the spread of ST59 within the USA in more
detail, as well as within East Asia; for example, mainland
China has contributed a substantial number of isolates
to world reporting since the mid-2000s.
As demonstrated in our study, CA-MRSA spreads fre-
quently at the intercontinental level and thus popula-
tions are exposed to different strains. However, the
dominance of S. aureus clones is known to vary within
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and between continents in the community setting. For
example, whilst ST59 is the most prevalent CA-MRSA
clone in Taiwan, in some other parts of Asia different
multi locus sequence types, including ST30, are known
to predominate (see [9, 31] for discussion). Furthermore,
the ST8 USA300 clone has become the dominant CA-
MRSA clone in North America but is less successful in
other parts of the world [6]. It has been suggested that
international travel could play a significant role in the
replacement of endemic S. aureus strains with those of
greater fitness [32]. However, the mechanisms through
which community-associated S. aureus strains become,
or remain, dominant within a geographical niche are yet
to be elucidated. A recent study of healthcare-associated
S. aureus infections concluded that clinical practice,
antibiotic usage and competition between bacterial
clones were important in determining nosocomial bac-
terial population dynamics [33]. Enhanced understand-
ing of the factors affecting clonal competition could
facilitate more accurate predictions about the spread of
emerging bacterial clones and their potential to compete
with resident strains [34].
We found that ST59 isolates from Taiwan possessed
a greater number of genes associated with antibiotic
resistance than isolates from the USA and were pre-
dicted to be resistant to a larger number of antibiotic
classes. Antibiotic usage can lead to resistance at the
population level [35] and high usage levels, including
non-prescription use [36], are thought to contribute
to the prevalence of antibiotic resistance in Taiwan
being amongst the highest in the world [37]. Macro-
lide and beta-lactam resistance genes (ermB and
mecA, respectively) were associated with the East Asia
ST59 clade in our study and high levels of resistance
to these drugs in Taiwan have also been reported for
another coloniser of the nasopharynx, Streptococcus
pneumoniae [38–40]. The chloramphenicol resistance
gene catA was also associated with the East Asia
clade; indeed, chloramphenicol resistance has been re-
ported amongst the earliest Taiwanese ST59 strains
[16, 41] and at high levels in other bacteria in this re-
gion (e.g. [42–44]). Although not widely prescribed
orally in humans today due to high toxicity levels,
and banned in food animals in Taiwan since 2003,
concerns have been voiced about illegal chloram-
phenicol use in aquaculture in parts of Southeast Asia
[45] and are the basis for the EU’s rejection of some
aquaculture products from Southeast Asia [46]. In
our study we identified the spread of resistant strains
into Europe that could have emerged due to anti-
biotic selection in a different location (Taiwan/East
Asia) and this should be addressed in greater detail
by enhanced global surveillance and future phylogen-
etic studies of larger datasets.
We hypothesise that the lack of transfer observed
between ST59 from Taiwan and the USA in our
phylogenetic analysis could relate to differences in
antibiotic resistance and usage in these regions. It is
possible that the USA strains are too susceptible to
antibiotics to become established in Taiwan, where
antibiotic usage is higher. Resistance mechanisms may
be associated with a fitness cost which manifests as a
reduced bacterial growth rate in the absence of anti-
biotic pressure [47, 48], and fitness costs have been
demonstrated for specific classes of antibiotic in S.
aureus [48]. Increased carriage of resistance determi-
nants might, therefore, lead the Taiwanese strains to
be outcompeted by USA ST59 or other S. aureus
strains in regions with lower levels of antibiotic
usage.
Although one might expect Europe to be more
similar to the USA than Taiwan in terms of antibiotic
use, we observed sub-clades of ST59 strains from
Europe in both the USA and East Asia clades, sug-
gestive of the capacity for onward transmission in
Europe of strains from both of these locations. In
considering why ST59 from both clades can spread in
Europe, we may need to consider competition dynam-
ics with the predominant community-associated
strains there such as ST80. Future studies comparing
the gene content of well-sampled groups of global
isolates from multiple clonal complexes of CA-MRSA,
including CC59, USA300 and ST80, could prove
useful in identifying the basis for the dominance of
particular clones in different geographical niches.
For community-associated S. aureus, direct competi-
tion between strains is likely to take place in the naso-
pharynx and might also involve competition with other
residents of that niche, such as S. pneumoniae [49],
which could be further investigated through laboratory
experiments. Indeed, it is possible that the most bio-
logically relevant competition that CA-MRSA strains
face is with the rest of the host microbiome, rather than
directly with other S. aureus strains. S. aureus is found
amongst the gut microbiota (discussed in [50]) as well as
the skin microbiota (discussed in [51]) and microbiome
content has been found to vary at the intercontinental
level, including between westernised and non-westernised
countries in the gut [52] and between the USA and Asia
(China) on skin sites [53]. Furthermore, host genetic vari-
ation, including between American and Asian popula-
tions, has recently been associated with differences in
microbiome content at a number of body sites [54]. We
therefore postulate that combining host ethnicity and
microbiome data (which were not available for the strains
we examined) could provide some explanation as to the
geographical exclusion observed between ST59 strains
from the USA and Taiwan in this study.
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Conclusions
We traced the emergence and dissemination of two
major clades of S. aureus ST59, one in the USA and one
in East Asia and, contrary to previous suggestions, did
not find evidence for the Taiwan ST59 clone having
emerged from the USA. Our quantitative analysis of the
global circulation of ST59 identified East Asia and the
USA as separate source populations and Europe and
Australia as sink populations, revealing pathways for the
global spread and frequent intercontinental transmission
of ST59 CA-MRSA. We also shed light on important
genomic differences between ST59 isolates from the
USA and Taiwan. Of note, the lack of direct exchange of
ST59 strains between the USA and Taiwan is striking
and may in part reflect their remarkably different pro-
files of mobile genetic elements. In particular, ST59
strains from Taiwan possess a much larger number of
antibiotic resistance genes than the USA strains, an ob-
servation that is consistent with distinct cultures of anti-
biotic usage in the different regions. Taken together,
these findings highlight the critical requirement for a
global strategy to control the emergence and dissemin-
ation of antibiotic-resistant clones.
Methods
CC59 isolates
We obtained CC59 isolates from laboratories around the
world (in the UK, Netherlands, USA, Taiwan and
Australia) to reflect the global distribution of countries
where CC59 samples have been identified and are avail-
able (Table 1; Additional file 1: Figure S1 and Figure S2).
The date (year) and country in which each sample was
taken were also obtained. DNA was extracted using a
commercial kit.
Sequencing, assembly and alignment
Whole-genome sequencing, using the Illumina Mi-Seq
platform, was performed by Edinburgh Genomics at
the Roslin Institute, Edinburgh, United Kingdom.
Short reads from the Illumina sequencing were aligned by
mapping to an ST59 reference sequence (GenBank
accession CP003166) using the Burrows–Wheeler
Aligner (BWA) with the Smith-Waterman algorithm
disabled [55] as outlined previously [56]. A core gen-
ome alignment was created from the consensus se-
quences, with the core genome defined as nucleotide
sites shared by all sequences (alignment columns that
did not contain a gap character or unknown nucleo-
tide identity). Sites were excluded if there was an ‘N’
base-call or a gap at that position for any sequence.
(See Additional file 2 for list of included sites, relative
to the reference genome.) Our core genome alignment
was 2,442,017 base pairs in length, of which 7061 sites
were variable.
In silico multi-locus sequence typing
SRST2 [57] was used to align short reads to reference al-
leles for the seven housekeeping loci used to define
multi-locus sequence types to determine whether iso-
lates belonged to CC59. Multi-locus sequence typing
analysis revealed 101 isolates (84 % of the 120 isolates)
to be ST59, with other sequence types (ST87, ST338,
ST375, ST952) which are single locus variants of ST59
also represented in the dataset at much lower levels (0.8,
5, 1.6 and 0.8 %, respectively). Nine isolates, all of which
had been identified as ST59 in the laboratory, were more
difficult to assign multi-locus sequence types to using
the in silico method: two matched the ST59 allelic pro-
file except for containing a single-nucleotide polymorph-
ism (SNP) at one locus; five matched the ST59 profile
except for some uncertainty (e.g. low coverage) at one or
more loci, and for two isolates the multi-locus sequence
types could not be determined. ST59 isolates were found
in all of the five countries studied. Subsequent maximum
likelihood phylogenetic analysis of the core genome did
not reveal any outlying sequences, including amongst iso-
lates with the novel or undefined sequence types.
Recombination detection
The core genome alignment was screened for recombin-
ation using the BratNextGen [58] software, three differ-
ent methods in RDP v4.19 [59] and a single breakpoint
analysis [60] in the HyPhy software [61]. Putative recom-
binant regions were removed prior to phylogenetic ana-
lysis (the region from sites 192166–192887 inclusive was
removed from the core genome), although this did not
affect the phylogenetic clustering into major clades.
Preliminary phylogenetic analysis of CC59
Maximum likelihood phylogenetic analyses were carried
out using neighbour-joining methods in MEGA v5.2
[62], maximum likelihood in RAxML (Linux version
v7.2.8) [63] and PhyML v3.0 [64]. The GTR nucleotide
substitution model was used, with gamma-distributed
rate heterogeneity across sites and 1000 bootstrap repli-
cates performed. The resulting phylogenetic trees were
rooted at the midpoint between the two most divergent
taxa in the tree. The temporal signal present in the data-
set was investigated through a plot of root-to-tip dis-
tance against the year of sampling in TempEst [65] and
a linear regression was carried out in R to assess the sig-
nificance of this relationship. An overall pattern of in-
creasing root-to-tip distance with sampling date was
observed, indicating that diversity had accumulated in a
clock-like fashion over time (Additional file 1: Figure S11).
Phylogeographic analysis of the global dispersal of CC59
A Bayesian phylogeographic analysis of the global dis-
semination of ST59 on an explicit time-scale (labelling
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sequences by their year or sampling) was carried out
using the BEAST software [66]. A relaxed (uncorrelated
lognormal) molecular clock model and a relaxed demo-
graphic prior (Bayesian skyride) were selected on the
basis of Bayes factor testing between different molecular
clock models and coalescent tree-priors. An HKY85 [67]
model of nucleotide substitution was selected, with
gamma-distributed rate variation and a proportion of in-
variant sites.
Sequences were labelled according to the country of
sampling and the dissemination of CC59 between coun-
tries was modelled in BEAST as a continuous-time
Markov chain [68]. The Bayesian stochastic search vari-
able selection (BSSVS) procedure was used to identify
links between countries which were required in a sym-
metric diffusion model to most parsimoniously explain
the observed pattern of sampling locations at the tips of
the phylogeny (using Bayes factor cutoffs of (i) 20 and
(ii) 3). In order to quantify transitions in and out of dif-
ferent countries, a Markov jumps analysis [69–72] was
implemented under an asymmetric diffusion model to
count the number of jumps across the phylogeny sam-
ples from one country to another. The Markov jumps
log files were processed in R to investigate the number
CC59 jumps in and out of different countries over time.
Subsampling analysis
To assess the robustness of our phylogeographic infer-
ence to biases in the dataset which could occur through
uneven sampling, we conducted phylogeographic ana-
lyses on ten subsampled datasets. Subsampling of the
original dataset with respect to date and country of sam-
pling was performed to thin the original dataset of 120
sequences in one of two ways: (i) five datasets of 50 se-
quences (ten per country, randomly sampled across
years) were obtained; (ii) five datasets of 50 sequences
were sampled as in (i) but omitting sequences sampled
before 2002 to remove potential bias arising from uneven
distributions of available sequences across countries be-
fore this point. Markov jumps and BSSVS analyses were
conducted on the subsampled datasets using the same ap-
proach as described for the full dataset.
De novo assembly and accessory genome analysis
De novo assembly of genomes for the 120 CC59 isolates
described in the phylogenetic analysis was carried out
using SPAdes [73] and the assemblies were annotated
using Prokka [74]. The NUCmer software [75] was used
to create a reference pangenome by stepwise addition of
new genes found in each of the CC59 genomes. The bi-
directional best hits (BDBH) method in get_homologues
[76] was used to compare all CC59 assemblies against
the reference pangenome. The presence or absence of all
genes in the reference pangenome was determined for
each of the 120 ST59 isolates based upon chosen simi-
larity and coverage thresholds as well as paralogous
genes within genomes. A range of thresholds were con-
sidered (default settings were compared with similarity
values of 70, 80 and 90 %, all with coverage = 75 % and
E-value = 1e-05). Tabulated pan-genome matrices were
created using the compare_clusters.pl script downloaded
as part of the get_homologues package.
The resulting pangenome matrix was coded to binary,
with 0 representing absence and entries greater than 0
(i.e. including groups of paralogous genes) coded to 1 to
signify the presence of a gene. Columns (corresponding
to genes) with less than 10 % variability with respect to
gene presence or absence across the CC59 genomes
were removed and heat maps of gene presence and ab-
sence were plotted using heatmap.2 in the gplots pack-
age in R. Hierarchical clustering was used to group the
isolates according to similarity in the distribution of
accessory genes.
In silico detection of antibiotic resistance genes and SNPs
SRST2 [57] was used to detect genes known to be anti-
biotic resistance determinants by mapping the short read
data against reference gene sequences from the ARG-
ANNOT database [77]. Association of resistance genes
with CC59 isolates from Taiwan or the USA was tested
using Fisher’s exact tests with a Bonferroni multiple test-
ing correction. BLAST was used to search for SNPs in
the gryA, grlA and grlB genes associated with resistance
to ciprofloxacin, using a list of SNPs from [78]. Presence
or absence of PVL was determined from the short read
data using the procedure described in [25]. Output used
to generate Fig. 4 can be found in Additional file 3.
In addition, Fisher’s exact test was used to identify
genes identified from the pangenome analysis whose
presence or absence differed significantly between (i) the
‘Taiwan’ or ‘USA’ clades or (ii) isolates from Taiwan or
the USA (i.e. excluding genomes from other countries).
The direction of association was also identified (see
Additional file 4 for significant genes). A Bonferroni cor-
rection based upon the number of column patterns
(with each column representing the distribution of a par-
ticular gene across the 120 isolates) for multiple testing
was applied, which is conservative but would reduce the
chance of genes being identified spuriously as associated
with either clade. Gene name information was taken
from the Prokka annotations and from additional
BLAST searches of protein sequences against the
TrEMBL and SWISS-PROT databases for sequences la-
belled ‘hypothetical protein’ by Prokka. A literature
search was conducted to identify members of the set of
significant genes which have been found to be associated
with antibiotic resistance, bacterial virulence or patho-
genesis or bacterial competition.
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Additional file 1: Supplementary figures and table of isolates. Figure S1.
Global distribution of reported ST59 isolates and sequencing in our study.
Figure S2. Spatiotemporal distribution of CC59 sequences in this study.
Figure S3. Maximum likelihood phylogeny of global CC59 sequences from
humans. Figure S4. BEAST maximum clade credibility tree of global human
CC59 sequences from humans. Figure S5. Posterior probabilities for
ancestral location of USA-associated clade in subsampled runs. Figure S6.
Posterior probabilities for ancestral location of East Asia-associated clade in
subsampled runs. Figure S7. Bayes factors indicating support for links
between countries in a symmetric BSSVS phylogeography analysis.
Figure S8. Skyride plots for subsampled runs. Figure S9. Heatmaps
of median number of transitions between countries for subsampled runs.
Figure S10. Presence or absence of accessory genes amongst global CC59
isolates. Figure S11. Root-to-tip distance plot for RAxML phylogeny
of S. aureus CC59 sequences. Table S1. 120 ST59 isolates included in
phylogenetic analysis. (DOCX 1792 kb)
Additional file 2: List of core genome sites included in our analysis. Site
numbers are relative to the published ST59 genome used as a reference
for mapping short reads (GenBank accession CP003166). (TXT 20378 kb)
Additional file 3: Output from in silico antibiotic resistance testing.
Genes associated with antibiotic resistance were detected using SRST2.
Gene presence is denoted by the name of the gene (asterisks indicates at
least one mismatched SNP or indel and a question mark indicates some
low-depth bases, as described on the SRST2 website: https://github.com/
katholt/srst2). Gene absence is denoted by a hyphen. The amino acid
residue (IUPAC single letter code) is given for gyrA, grlA and grlB sites
associated with fluoroquinolone resistance. Presence or absence of
PVL based on mapping of short reads to lukF-PV and lukS-PV reference
sequences is also reported. (XLSX 16 kb)
Additional file 4: Genes associated with either USA or East Asia clade.
Genes whose presence differed significantly between the USA and East
Asia clades are listed. We also report the proportion of isolates within the
USA and East Asia clades for which each gene was present and note
those that share the same pattern of presence or absence across the
isolates (identified by having the same ‘column pattern’). Results for
genes whose presence differed significantly between the USA and
Taiwan isolates (as opposed to the USA and East Asia clades) are
presented in a separate worksheet. (XLSX 26 kb)
Abbreviations
BSSVS, Bayesian stochastic search variable selection; CA-MRSA, community-
associated MRSA; CC, clonal complex; HPD, highest posterior density; MRSA,
methicillin-resistant Staphylococcus aureus; PP, posterior probability; PVL,
Panton-Valentine leukocidin; SNP, single nucleotide polymorphism; ST, (multi
locus) sequence type
Acknowledgements
We thank Edinburgh Genomics for sequencing and Matthew Hall for
providing an R script for subsampling sets of sequences by country and date
of sampling. We are grateful to Sam Brown, Luke McNally and Roman Popat
for helpful discussions.
Funding
This project was supported by a project grant (BB/K00638X/1) and institute
strategic grant funding (ISP3: BB/J004227/1) from the Biotechnology and
Biological Sciences Research Council (UK) to JRF. MJW was supported by the
Evolution and Transfer of Antibiotic Resistance project (EvoTAR; European
Commission Framework Programme 7) and by a Research Fellowship as part
of a Wellcome Trust Strategic grant to the Centre for Immunity, Infection
and Evolution at the University of Edinburgh (grant reference number
095831).
Availability of data and materials
Illumina sequencing data generated and analysed during the current study
are available in the European Nucleotide Archive repository at http://
www.ebi.ac.uk/ena/data/view/PRJEB12470 with sample accession numbers
ERS1043222–ERS1043341.
Authors’ contributions
JRF conceived the study. MJW performed bioinformatics and phylogenetic
analyses. MJW and JRF wrote the manuscript. MG performed laboratory
experiments. ER-1 and ER-2 provided assistance with bioinformatics. PM
performed bioinformatics analysis of resistance genes. ER-2 obtained CC59
strains from laboratories. AK, RD, MD, TSL, KG and GE identified and provided
putative CC59 strains for sequencing. MEJW provided guidance on study
design. All authors revised and approved the final manuscript.
Competing interests
The authors declare that they have no competing interests.
Ethics approval and consent to participate
No ethics approval was required for this work.
Author details
1Centre for Immunity, Infection and Evolution, University of Edinburgh,
Edinburgh, UK. 2The Roslin Institute, University of Edinburgh, Edinburgh, UK.
3Public Health England, Colindale, UK. 4University of Chicago, Chicago, IL,
USA. 5National Health Research Institutes, Zhunan, Taiwan. 6Scottish MRSA
Reference Laboratory, NHS Greater Glasgow and Clyde, Glasgow, UK. 7Griffith
University School of Medicine, Gold Coast, QLD, Australia. 8Australian
Collaborating Centre for Enterococcus and Staphylococcus Species (ACCESS)
Typing and Research, Murdoch University, Perth, Australia. 9National Institute
for Public Health and the Environment, Bilthoven, The Netherlands.
Received: 2 June 2016 Accepted: 8 July 2016
References
1. David MZ, Daum RS. Community-associated methicillin-resistant
Staphylococcus aureus: epidemiology and clinical consequences of an
emerging epidemic. Clin Microbiol Rev. 2010;23(3):616–87.
2. Ma XX, et al. Novel type of staphylococcal cassette chromosome mec
identified in community-acquired methicillin-resistant Staphylococcus
aureus strains. Antimicrob Agents Chemother. 2002;46(4):1147–52.
3. Ito T, et al. Novel type V staphylococcal cassette chromosome mec driven
by a novel cassette chromosome recombinase, ccrC. Antimicrob Agents
Chemother. 2004;48(7):2637–51.
4. Naimi TS, et al. Comparison of community- and health care-associated
methicillin-resistant Staphylococcus aureus infection. JAMA. 2003;290(22):2976–84.
5. Naas T, et al. Three-year survey of community-acquired methicillin-resistant
Staphylococcus aureus producing Panton-Valentine leukocidin in a French
university hospital. J Hosp Infect. 2005;61(4):321–9.
6. Monecke S, et al. A field guide to pandemic, epidemic and sporadic clones
of methicillin-resistant Staphylococcus aureus. PLoS One. 2011;6(4):e17936.
7. Moran GJ, et al. Methicillin-resistant S. aureus infections among patients in
the emergency department. N Engl J Med. 2006;355(7):666–74.
8. Huang YC, Chen CJ. Community-associated meticillin-resistant
Staphylococcus aureus in children in Taiwan, 2000s. Int J Antimicrob
Agents. 2011;38(1):2–8.
9. Chen CJ, Huang YC. New epidemiology of Staphylococcus aureus infection
in Asia. Clin Microbiol Infect. 2014;20(7):605–23.
10. Chuang YY, Huang YC. Molecular epidemiology of community-associated
meticillin-resistant Staphylococcus aureus in Asia. Lancet Infect Dis.
2013;13(8):698–708.
11. Takano T, et al. Spread of community-acquired methicillin-resistant
Staphylococcus aureus (MRSA) in hospitals in Taipei, Taiwan in 2005, and
comparison of its drug resistance with previous hospital-acquired MRSA.
Microbiol Immunol. 2007;51(6):627–32.
12. Chen CJ, et al. Characterization and comparison of 2 distinct epidemic
community-associated methicillin-resistant Staphylococcus aureus clones of
ST59 lineage. Plos One. 2013;8(9):e63210.
13. Diep BA, et al. Roles of 34 virulence genes in the evolution of hospital- and
community-associated strains of methicillin-resistant Staphylococcus aureus.
J Infect Dis. 2006;193(11):1495–503.
14. Coombs GW, et al. Differentiation of clonal complex 59 community-
associated methicillin-resistant Staphylococcus aureus in Western Australia.
Antimicrob Agents Chemother. 2010;54(5):1914–21.
Ward et al. Genome Biology  (2016) 17:160 Page 11 of 13
15. Takano T, et al. Novel characteristics of community-acquired methicillin-
resistant Staphylococcus aureus strains belonging to multilocus sequence
type 59 in Taiwan. Antimicrob Agents Chemother. 2008;52(3):837–45.
16. Boyle-Vavra S, et al. Successful multiresistant community-associated
methicillin-resistant Staphylococcus aureus lineage from Taipei,
Taiwan, that carries either the novel staphylococcal chromosome
cassette mec (SCCmec) type V-T or SCCmec type IV. J Clin Microbiol.
2005;43(12):6223–3.
17. Weinert LA, et al. Molecular dating of human-to-bovid host jumps by
Staphylococcus aureus reveals an association with the spread of
domestication. Biol Lett. 2012;8(5):829–32.
18. Shepheard MA, et al. Historical zoonoses and other changes in host tropism
of Staphylococcus aureus, identified by phylogenetic analysis of a
population dataset. PLoS One. 2013;8(5):e62369.
19. Hsu LY, et al. Community-associated meticillin-resistant Staphylococcus
aureus. Lancet. 2010;376(9743):767–7.
20. DeLeo FR, et al. Community-associated meticillin-resistant Staphylococcus
aureus. Lancet. 2010;375(9725):1557–68.
21. Vandenesch F, et al. Community-acquired methicillin-resistant Staphylococcus
aureus carrying Panton-Valentine leukocidin genes: worldwide emergence.
Emerg Infect Dis. 2003;9(8):978–84.
22. Mwangi AM. The role of urban agriculture in food security for low-income
households in Nairobi. Leiden: African Studies Centre; 1995.
23. Tristan A, et al. Global distribution of Panton-Valentine leukocidin-positive
methicillin-resistant Staphylococcus aureus, 2006. Emerg Infect Dis.
2007;13(4):594–600.
24. Holden M, et al. A genomic portrait of the emergence, evolution and global
spread of a methicillin resistant Staphylococcus aureus pandemic. Genome
Res. 2013;23(4):653–64.
25. Ward MJ, et al. Time-scaled evolutionary analysis of the transmission and
antibiotic resistance dynamics of Staphylococcus aureus clonal complex
398. Appl Environ Microbiol. 2014;80(23):7275–82.
26. Nunes MRT, et al. Phylogeography of dengue virus serotype 4, Brazil,
2010–2011. Emerg Infect Dis. 2012;18(11):1858–64.
27. Hall MD, et al. Reconstructing geographical movements and host
species transitions of foot-and-mouth disease virus serotype SAT 2.
Mbio. 2013;4(5):e00591–13.
28. Croucher NJ, et al. Diversification of bacterial genome content through distinct
mechanisms over different timescales. Nat Commun. 2014;5. Article number 5471.
29. de Silva E, Ferguson NM, Fraser C. Inferring pandemic growth rates from
sequence data. J R Soc Interface. 2012;9(73):1797–808.
30. Ward MJ. Evolutionary analysis of rapidly evolving RNA viruses. PhD thesis,
Institute for Evolutionary Biology, School of Biological Sciences, University of
Edinburgh, UK; 2013.
31. Huang TW, et al. Complete genome sequence of Staphylococcus aureus
M013, a PVL-positive, ST59-SCCmec type V strain isolated in Taiwan. J Bacteriol.
2012;194(5):1256–7.
32. Zhou YP, Wilder-Smith A, Hsu L. The role of international travel in the
spread of methicillin-resistant Staphylococcus aureus. J Travel Med.
2014;21(4):272–81.
33. Hsu LY, et al. Evolutionary dynamics of methicillin-resistant Staphylococcus
aureus within a healthcare system. Genome Biol. 2015;16:81.
34. Fitzgerald R. Inter-clonal wars: bacterial competition and global success in
the hospital setting. On Biology, BioMed Central; 2015. http://blogs.
biomedcentral.com/on-biology/2015/05/06
35. Lipsitch M, Samore MH. Antimicrobial use and antimicrobial resistance: a
population perspective. Emerg Infect Dis. 2002;8(4):347–54.
36. Morgan DJ, et al. Non-prescription antimicrobial use worldwide: a
systematic review. Lancet Infect Dis. 2011;11(9):692–701.
37. Liu YC, et al. Inappropriate use of antibiotics and the risk for delayed
admission and masked diagnosis of infectious diseasesa–a lesson from
Taiwan. Arch Intern Med. 2001;161(19):2366–70.
38. Chiou CCC, et al. Extremely high prevalence of nasopharyngeal carriage of
penicillin-resistant Streptococcus pneumoniae among children in
Kaohsiung, Taiwan. J Clin Microbiol. 1998;36(7):1933–7.
39. Hsueh PR, et al. Dissemination of high-level penicillin-, extended-spectrum
cephalosporin-, and erythromycin-resistant Streptococcus pneumoniae
clones in Taiwan. J Clin Microbiol. 1999;37(1):221–4.
40. Hsueh PR, et al. Extremely high incidence of macrolide and trimethoprim-
sulfamethoxazole resistance among clinical isolates of Streptococcus
pneumoniae in Taiwan. J Clin Microbiol. 1999;37(4):897–901.
41. Wang CC, et al. Epidemiological typing of community-acquired methicillin-
resistant Staphylococcus aureus isolates from children in Taiwan. Clin Infect
Dis. 2004;39(4):481–7.
42. Burger H, et al. Evolution and recombination of genes encoding HIV-1 drug
resistance and tropism during antiretroviral therapy. Virology. 2010;404(1):5–20.
43. Torpdahl M, et al. Human isolates of Salmonella enterica serovar Typhimurium
from Taiwan displayed significantly higher levels of antimicrobial resistance
than those from Denmark. Int J Food Microbiol. 2013;161(2):69–75.
44. Tsai H-Y, et al. Updated antibiotic resistance and clinical spectrum of
infections caused by Streptococcus pneumoniae in Taiwan: Emphasis on
risk factors for penicillin nonsusceptibilities. J Microbiol Immunol Infect.
2013;46(5):345–51.
45. Ng K, et al. Distribution and prevalence of chloramphenicol-resistance gene
in Escherichia coli isolated from aquaculture and other environment. Int
Food Res J. 2014;21(4):1321–5.
46. Chinabut S, et al. The use of antimicrobials in Asian aquaculture: aims of the
EU-ASIARESIST project. World Aquaculture. 2005. Available at: http://www.
medinfo.dist.unige.it/Asiaresist/Publications/WAS%20Abstract.pdf.
47. Andersson DI, Hughes D. Antibiotic resistance and its cost: is it possible to
reverse resistance? Nat Rev Microbiol. 2010;8(4):260–71.
48. Melnyk A, Wong A, Kassen R. The fitness costs of antibiotic resistance
mutations. Evol Appl. 2014;8(2015):273–83.
49. Melles DC, et al. Nasopharyngeal co-colonization with Staphylococcus
aureus and Streptococcus pneumoniae in children is bacterial genotype
independent. Microbiology-Sgm. 2007;153:686–92.
50. Vesterlund S, et al. Staphylococcus aureus adheres to human intestinal
mucus but can be displaced by certain lactic acid bacteria. Microbiology-
Sgm. 2006;152:1819–26.
51. Grice EA, Segre JA. The skin microbiome. Nat Rev Microbiol. 2011;9(4):244–53.
52. Yatsunenko T, et al. Human gut microbiome viewed across age and
geography. Nature. 2012;486(7402):222–7.
53. Leung MHY, et al. Insights into the pan-microbiome: skin microbial
communities of Chinese individuals differ from other racial groups. Sci Rep.
2015;5. Article number: 11845.
54. Blekhman R, et al. Host genetic variation impacts microbiome composition
across human body sites. Genome Biol. 2015;16:191.
55. Li H, Durbin R. Fast and accurate short read alignment with Burrows-
Wheeler transform. Bioinformatics. 2009;25(14):1754–60.
56. McAdam PR, et al. Molecular tracing of the emergence, adaptation and
transmission of hospital-associated methicillin-resistant Staphylococcus
aureus. Proc Nat Acad Sci U S A. 2012;109(23):9107–12.
57. Inouye M, et al. SRST2: rapid genomic surveillance for public health and
hospital microbiology labs. Genome Med. 2014;6:90.
58. Marttinen P, et al. Detection of recombination events in bacterial genomes
from large population samples. Nucleic Acids Res. 2012;40(1):e6.
59. Martin DP, et al. RDP3: a flexible and fast computer program for analyzing
recombination. Bioinformatics. 2010;26(19):2462–3.
60. Kosakovsky Pond SL, et al. Automated phylogenetic detection of
recombination using a genetic algorithm. Mol Biol Evol. 2006;23(10):1891–901.
61. Pond SL, Frost SD, Muse SV. HyPhy: hypothesis testing using phylogenies.
Bioinformatics. 2005;21(5):676–9.
62. Tamura K, et al. MEGA5: molecular evolutionary genetics analysis using
maximum likelihood, evolutionary distance, and maximum parsimony
methods. Mol Biol Evol. 2011;28(10):2731–9.
63. Stamatakis A. RAxML-VI-HPC: maximum likelihood-based phylogenetic
analyses with thousands of taxa and mixed models. Bioinformatics.
2006;22(21):2688–90.
64. Guindon S, et al. New algorithms and methods to estimate maximum-
likelihood phylogenies: assessing the performance of PhyML 3.0. Syst Biol.
2010;59(3):307–21.
65. Rambaut A. TempEst v1.4. http://tree.bio.ed.ac.uk/software/tempest/.
66. Drummond AJ, et al. Bayesian Phylogenetics with BEAUti and the BEAST 1.7.
Mol Biol Evol. 2012;29(8):1969–73.
67. Hasegawa M, Kishino H, Yano TA. Dating of the human ape splitting by a
molecular clock of mitochondrial-DNA. J Mol Evol. 1985;22(2):160–74.
68. Lemey P, et al. Bayesian phylogeography finds its roots. PLoS Comput Biol.
2009;5(9):e1000520.
69. Minin VN, Suchard MA. Counting labeled transitions in continuous-time
Markov models of evolution. J Math Biol. 2008;56(3):391–412.
70. Minin VN, Suchard MA. Fast, accurate and simulation-free stochastic
mapping. Philos Trans R Soc B Biol Sci. 2008;363(1512):3985–95.
Ward et al. Genome Biology  (2016) 17:160 Page 12 of 13
71. O'Brien JD, Minin VN, Suchard MA. Learning to count: robust estimates
for labeled distances between molecular sequences. Mol Biol Evol.
2009;26(4):801–14.
72. Talbi C, et al. Phylodynamics and human-mediated dispersal of a zoonotic
virus. PLoS Pathogens. 2010;6(10):e1001166.
73. Bankevich A, et al. SPAdes: a new genome assembly algorithm and its
applications to single-cell sequencing. J Comput Biol. 2012;19(5):455–77.
74. Seemann T. Prokka: rapid prokaryotic genome annotation. Bioinformatics.
2014;30(14):2068–9.
75. Kurtz S, et al. Versatile and open software for comparing large genomes.
Genome Biol. 2004;5(2):R12.
76. Contreras-Moreira B, Vinuesa P. GET_HOMOLOGUES, a versatile software
package for scalable and robust microbial pangenome analysis. Appl
Environ Microbiol. 2013;79(24):7696–701.
77. ARG-ANNOT database. http://en.mediterranee-infection.com/article.
php?laref=283%26titre=arg-annot-.
78. Gordon NC, et al. Prediction of Staphylococcus aureus antimicrobial
resistance by whole-genome sequencing. J Clin Microbiol. 2014;52(4):1182–91.
•  We accept pre-submission inquiries 
•  Our selector tool helps you to find the most relevant journal
•  We provide round the clock customer support 
•  Convenient online submission
•  Thorough peer review
•  Inclusion in PubMed and all major indexing services 
•  Maximum visibility for your research
Submit your manuscript at
www.biomedcentral.com/submit
Submit your next manuscript to BioMed Central 
and we will help you at every step:
Ward et al. Genome Biology  (2016) 17:160 Page 13 of 13
